SIRPRAKULINE ANEEMIA (LASTEL)
Transfusion Risks and Uncertainties
eesti
Transfusion Risks and Uncertainties
https://assetsnffrgf-a.akamaihd.net/assets/ct/d71826a198/images/syn_placeholder_sqr.png

Sirprakuline aneemia (lastel)

Transfusion Risks and Uncertainties

Primary hemorrhagic stroke in children with sickle cell disease is associated with recent transfusion and use of corticosteroids. (avab uue akna)

Strouse JJ, Hulbert ML, DeBaun MR, Jordan LC, Casella JF.

Allikas‎: Pediatrics 2006;118(5):1916-24.

Indekseeritud‎: PubMed 17079562

DOI‎: 10.1542/peds.2006-1241

https://www.ncbi.nlm.nih.gov/pubmed/17079562 (avab uue akna)

Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease. (avab uue akna)

Talano JA, Hillery CA, Gottschall JL, Baylerian DM, Scott JP.

Allikas‎: Pediatrics 2003;111(6 Pt 1):e661-5.

Indekseeritud‎: PubMed 12777582

https://www.ncbi.nlm.nih.gov/pubmed/12777582 (avab uue akna)

Prevalence of human immunodeficiency virus transmission among transfused children with sickle cell anemia in Enugu Nigeria. (avab uue akna)

Ubesie A, Emodi I, Ikefuna A, Ilechukwu G, Ilechukwu G.

Allikas‎: Ann Med Health Sci Res 2012;2(2):109-13.

Indekseeritud‎: PubMed 23439999

DOI‎: 10.4103/2141-9248.105655

https://www.ncbi.nlm.nih.gov/pubmed/23439999 (avab uue akna)